Library / Laws / 119th Congress / Senate Bills / S. 822
S. 822
To amend the Federal Food, Drug, and Cosmetic Act to establish a process for science-focused drug development meetings led by the Reagan-Udall Foundation for the Food and Drug Administration with respect to drugs for rare diseases and conditions, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | — | 10.0K | ⠃⠗⠋ |